Jonathan Zuckerman, MD, PHD

NPI: 1205246337
Total Payments
$15,890
2024 Payments
$2,391
Companies
4
Transactions
18
Medicare Patients
2,741
Medicare Billing
$186,916

Payment Breakdown by Category

Consulting$15,075 (94.9%)
Food & Beverage$815.14 (5.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $15,075 11 94.9%
Food and Beverage $815.14 7 5.1%

Top Paying Companies

Company Total Records Latest Year
LEICA MICROSYSTEMS INC. $15,075 11 $0 (2024)
Alexion Pharmaceuticals, Inc. $501.29 4 $0 (2024)
Novartis Pharmaceuticals Corporation $185.45 2 $0 (2024)
Travere Therapeutics, Inc. $128.40 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,391 5 LEICA MICROSYSTEMS INC. ($1,950)
2023 $2,400 1 LEICA MICROSYSTEMS INC. ($2,400)
2022 $5,080 2 LEICA MICROSYSTEMS INC. ($4,950)
2021 $300.00 1 LEICA MICROSYSTEMS INC. ($300.00)
2020 $975.00 4 LEICA MICROSYSTEMS INC. ($975.00)
2019 $4,744 5 LEICA MICROSYSTEMS INC. ($4,500)

All Payment Transactions

18 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/24/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $126.86 General
Category: Immunology
08/09/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $58.59 General
08/08/2024 Travere Therapeutics, Inc. Food and Beverage In-kind items and services $128.40 General
04/27/2024 LEICA MICROSYSTEMS INC. Consulting Fee Cash or cash equivalent $1,950.00 General
04/17/2024 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $127.50 General
03/08/2023 LEICA MICROSYSTEMS INC. HydroMARK Breast Biopsy Site Marker (Device) Consulting Fee Cash or cash equivalent $2,400.00 General
Category: Devices
08/04/2022 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $129.75 General
08/03/2022 LEICA MICROSYSTEMS INC. Consulting Fee Cash or cash equivalent $4,950.00 General
07/10/2021 LEICA MICROSYSTEMS INC. NONE (Device) Consulting Fee Cash or cash equivalent $300.00 General
Category: Devices
12/17/2020 LEICA MICROSYSTEMS INC. DIGITAL MICROSCOPES (Device) Consulting Fee Cash or cash equivalent $75.00 General
Category: CANCER DIAGNOSTICS
12/10/2020 LEICA MICROSYSTEMS INC. DIGITAL MICROSCOPES (Device) Consulting Fee Cash or cash equivalent $225.00 General
Category: CANCER DIAGNOSTICS
12/05/2020 LEICA MICROSYSTEMS INC. DIGITAL MICROSCOPES (Device) Consulting Fee Cash or cash equivalent $150.00 General
Category: CANCER DIAGNOSTICS
09/28/2020 LEICA MICROSYSTEMS INC. DIGITAL MICROSCOPES (Device) Consulting Fee Cash or cash equivalent $525.00 General
Category: CANCER DIAGNOSTICS
10/14/2019 LEICA MICROSYSTEMS INC. DIGITAL MICROSCOPES (Device) Consulting Fee Cash or cash equivalent $250.00 General
Category: CANCER DIAGNOSTICS
09/28/2019 LEICA MICROSYSTEMS INC. DIGITAL MICROSCOPES (Device) Consulting Fee Cash or cash equivalent $2,750.00 General
Category: CANCER DIAGNOSTICS
09/12/2019 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $121.90 General
08/04/2019 LEICA MICROSYSTEMS INC. DIGITAL MICROSCOPES (Device) Consulting Fee Cash or cash equivalent $1,500.00 General
Category: CANCER DIAGNOSTICS
05/06/2019 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $122.14 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 580 1,428 $206,728 $35,019
2022 10 588 1,339 $208,603 $35,263
2021 12 766 1,861 $343,175 $57,539
2020 13 807 1,996 $324,103 $59,096
Total Patients
2,741
Total Services
6,624
Medicare Billing
$186,916
Procedure Codes
49

All Medicare Procedures & Services

49 procedure records from CMS Medicare Utilization — Page 2 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
88360 Microscopic genetic analysis of tumor, manual Facility 2021 30 108 $32,400 $4,012 12.4%
88307 Pathology examination of tissue using a microscope, moderately high complexity Facility 2021 25 51 $20,400 $3,624 17.8%
88313 Special stained specimen slides to examine tissue including interpretation and report Facility 2021 103 327 $21,255 $3,467 16.3%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2021 90 111 $20,707 $3,426 16.5%
88346 Antibody evaluation, initial single antibody stain procedure Facility 2021 86 96 $18,221 $3,060 16.8%
88305 Pathology examination of tissue using a microscope, intermediate complexity Office 2021 32 72 $17,490 $2,355 13.5%
88341 Special stained specimen slides to examine tissue, each additional procedure Facility 2021 37 65 $10,400 $1,637 15.7%
88377 Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure Facility 2021 27 28 $9,660 $1,579 16.3%
88300 Pathology examination of tissue using a microscope, limited examination Facility 2021 23 28 $1,174 $109.86 9.4%
88350 Antibody evaluation Facility 2020 99 588 $82,320 $15,309 18.6%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2020 135 243 $29,403 $8,171 27.8%
88348 Electron microscopy for diagnosis Facility 2020 83 92 $34,040 $6,305 18.5%
88331 Pathology examination of tissue during surgery Facility 2020 23 84 $28,812 $4,722 16.4%
88313 Special stained specimen slides to examine tissue including interpretation and report Facility 2020 114 407 $26,455 $4,375 16.5%
88346 Antibody evaluation Facility 2020 104 124 $23,436 $3,982 17.0%
88360 Microscopic genetic analysis of tumor Facility 2020 24 88 $26,400 $3,330 12.6%
88342 Tissue or cell analysis by immunologic technique Facility 2020 82 103 $16,995 $3,254 19.1%
88341 Special stained specimen slides to examine tissue Facility 2020 43 111 $17,760 $2,824 15.9%
88307 Pathology examination of tissue using a microscope, moderately high complexity Facility 2020 17 37 $14,800 $2,764 18.7%
88377 Microscopic genetic examination manual Facility 2020 19 22 $7,590 $1,267 16.7%
88305 Pathology examination of tissue using a microscope, intermediate complexity Office 2020 21 39 $6,951 $1,252 18.0%
88342 Tissue or cell analysis by immunologic technique Office 2020 11 21 $5,215 $1,010 19.4%
88365 Analysis of genetic material Facility 2020 11 11 $2,860 $432.22 15.1%
88300 Pathology examination of tissue using a microscope, limited examination Facility 2020 21 26 $1,066 $98.98 9.3%

About Jonathan Zuckerman, MD, PHD

Jonathan Zuckerman, MD, PHD is a Anatomic Pathology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2014. The National Provider Identifier (NPI) number assigned to this provider is 1205246337.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jonathan Zuckerman, MD, PHD has received a total of $15,890 in payments from pharmaceutical and medical device companies, with $2,391 received in 2024. These payments were reported across 18 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($15,075).

As a Medicare-enrolled provider, Zuckerman has provided services to 2,741 Medicare beneficiaries, totaling 6,624 services with total Medicare billing of $186,916. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.

Practice Information

  • Specialty Anatomic Pathology
  • Location Los Angeles, CA
  • Active Since 04/28/2014
  • Last Updated 04/28/2014
  • Taxonomy Code 207ZP0101X
  • Entity Type Individual
  • NPI Number 1205246337

Products in Payments

  • DIGITAL MICROSCOPES (Device) $5,475
  • HydroMARK Breast Biopsy Site Marker (Device) $2,400
  • NONE (Device) $300.00
  • Fabhalta (Drug) $126.86

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anatomic Pathology Doctors in Los Angeles